Penn I
Cancer. 1976 Feb;37(2 Suppl):1024-32. doi: 10.1002/1097-0142(197602)37:2+<1024::aid-cncr2820370806>3.0.co;2-v.
Previous studies have shown that immunosuppressive therapy permits the growth and spread of inadvertently transplanted malignant cells in man, and, in addition, is associated with a 5 to 6% incidence of de novo cancers in organ homograft recipients who were apparently free of cancer before and at the time of transplantation. In the present report two further groups of patients were studied. There was a 4% incidence of new tumors in 101 organ homograft recipient- who had had pre-existing cancers. The immunosuppressive effects of cancer chemotherapeutic agents may have been responsible for the development of 166 new malignancies in 160 patients who received treatment for 161 neoplasms. This does not contraindicate the use of chemotherapy in patients with advanced or widespread neoplasms, as the occasional development of new malignancies is far outweighed by the many months or years of control of the original tumors.
以往的研究表明,免疫抑制疗法会使人体内意外移植的恶性细胞生长和扩散,此外,在器官同种移植受者中,有5%至6%会发生原发性癌症,这些受者在移植前和移植时显然没有癌症。在本报告中,对另外两组患者进行了研究。101名患有既往癌症的器官同种移植受者中新发肿瘤的发生率为4%。癌症化疗药物的免疫抑制作用可能是160名接受161种肿瘤治疗的患者发生166种新恶性肿瘤的原因。这并不妨碍对晚期或广泛肿瘤患者使用化疗,因为新恶性肿瘤的偶尔发生与原肿瘤得到数月或数年的控制相比,显得微不足道。